{"id":"https://openalex.org/W2235173296","doi":null,"title":"The differences between typical and atypical antipsychotics: the effects on neurogenesis.","display_name":"The differences between typical and atypical antipsychotics: the effects on neurogenesis.","publication_year":2012,"publication_date":"2012-09-01","ids":{"openalex":"https://openalex.org/W2235173296","mag":"2235173296","pmid":"https://pubmed.ncbi.nlm.nih.gov/22945197"},"language":"en","primary_location":{"id":"pmid:22945197","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22945197","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatria Danubina","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061485289","display_name":"Karandeep Singh Nandra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Karandeep Singh Nandra","raw_affiliation_strings":["Clare College Cambridge, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clare College Cambridge, Cambridge, UK","institution_ids":["https://openalex.org/I241749"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101428835","display_name":"Mark A Agius","orcid":"https://orcid.org/0000-0002-5929-8580","observed_orcids":["https://orcid.org/0000-0002-5929-8580"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark Agius","raw_affiliation_strings":["Clare College Cambridge, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clare College Cambridge, Cambridge, UK","institution_ids":["https://openalex.org/I241749"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I241749"],"apc_list":null,"apc_paid":null,"fwci":3.9907,"has_fulltext":false,"cited_by_count":51,"citation_normalized_percentile":{"value":0.93872382,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"24 Suppl 1","issue":null,"first_page":"S95","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.9860000014305115},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":1.0},{"id":"https://openalex.org/keywords/neurogenesis","display_name":"neurogenesis","score":0.9850000143051147},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.7440000176429749},{"id":"https://openalex.org/keywords/brain-derived-neurotrophic-factor","display_name":"brain-derived neurotrophic factor","score":0.7459999918937683},{"id":"https://openalex.org/keywords/neurotrophins","display_name":"neurotrophins","score":0.9850000143051147},{"id":"https://openalex.org/keywords/neuronal-apoptosis","display_name":"neuronal apoptosis","score":0.597000002861023},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.703000009059906},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8059999942779541},{"id":"https://openalex.org/keywords/gray-matter-reduction","display_name":"gray matter reduction","score":0.6930000185966492},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.8980000019073486},{"id":"https://openalex.org/keywords/cytochrome-c-translocation","display_name":"cytochrome c translocation","score":0.6809999942779541},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.865815281867981},{"id":"https://openalex.org/C4746552","wikidata":"https://www.wikidata.org/wiki/Q1456827","display_name":"Neurogenesis","level":2,"score":0.8565139174461365},{"id":"https://openalex.org/C92020748","wikidata":"https://www.wikidata.org/wiki/Q420457","display_name":"Neurotrophin","level":3,"score":0.5601577162742615},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4970569908618927},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.48893776535987854},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.48348718881607056},{"id":"https://openalex.org/C2775870346","wikidata":"https://www.wikidata.org/wiki/Q2554162","display_name":"Typical antipsychotic","level":5,"score":0.4761926233768463},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.45517897605895996},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.45048874616622925},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.41636183857917786},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.4097106158733368},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.40300506353378296},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38343679904937744},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23826777935028076},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2308775782585144},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.18982595205307007},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.09314525127410889}],"mesh":[{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009414","descriptor_name":"Nerve Growth Factors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D019208","descriptor_name":"Brain-Derived Neurotrophic Factor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D044402","descriptor_name":"Receptor, Serotonin, 5-HT2A","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D055495","descriptor_name":"Neurogenesis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D055495","descriptor_name":"Neurogenesis","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:22945197","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22945197","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatria Danubina","raw_type":"Journal Article"},{"id":"mag:2235173296","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22945197","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1963925910","https://openalex.org/W1966023781","https://openalex.org/W1974098658","https://openalex.org/W1979363849","https://openalex.org/W1988869202","https://openalex.org/W2006023522","https://openalex.org/W2014204077","https://openalex.org/W2018487237","https://openalex.org/W2018851857","https://openalex.org/W2025693768","https://openalex.org/W2032487256","https://openalex.org/W2044623410","https://openalex.org/W2061191067","https://openalex.org/W2067856703","https://openalex.org/W2067899349","https://openalex.org/W2071727158","https://openalex.org/W2075856517","https://openalex.org/W2079530654","https://openalex.org/W2090912262","https://openalex.org/W2145240519","https://openalex.org/W2146264275","https://openalex.org/W2170915041","https://openalex.org/W2193090477"],"related_works":["https://openalex.org/W2079530654","https://openalex.org/W2114678425","https://openalex.org/W1963630844","https://openalex.org/W2185591574","https://openalex.org/W2105237077","https://openalex.org/W1886052836","https://openalex.org/W2068557183","https://openalex.org/W2025149917","https://openalex.org/W2075856517","https://openalex.org/W1995638515"],"abstract_inverted_index":{"Recently,":[0],"the":[1,83,86,88,106,113,143,173,182,191,195],"pharmacological":[2],"division":[3],"between":[4,22],"typical":[5,29,114],"and":[6,30,46,66,82,131,163],"atypical":[7,31],"antipsychotics":[8,32],"has":[9,69],"been":[10,70],"called":[11],"into":[12],"question.":[13],"New":[14],"evidence,":[15],"however,":[16],"continues":[17],"to":[18,72,145],"emerge":[19],"showing":[20],"differences":[21],"these":[23,109],"two":[24],"classes":[25,36,57],"of":[26,37,58,76,96,108,112,158,175,185,190],"drugs.":[27],"Hence":[28],"are":[33],"clearly":[34],"different":[35],"drugs,":[38],"as":[39],"evidenced":[40],"by":[41,119],"their":[42],"actions,":[43],"mechanisms,":[44],"effects":[45,62,174],"side":[47],"effects.":[48,149,154],"The":[49,102,179],"most":[50],"recently":[51],"investigated":[52],"field":[53],"in":[54,79,142],"which":[55],"both":[56],"drugs":[59,104,151,167],"have":[60,93,152],"opposing":[61,153],"is":[63,197],"neuron":[64,117],"survival":[65,162],"neurogenesis.":[67,165],"Schizophrenia":[68],"found":[71],"be":[73],"a":[74,120],"disease":[75],"progressive":[77],"reductions":[78],"grey":[80],"matter,":[81],"more":[84,199],"lost,":[85],"worse":[87],"outcome.":[89],"Medication":[90],"naive":[91],"patients":[92],"lowered":[94],"levels":[95,107,157],"neurotrophins":[97],"e.g.":[98],"NT-3,":[99],"NGF":[100],"BDNF.":[101],"antipsychotic":[103],"alter":[105],"neurotrophins.":[110],"Haloperidol,":[111],"antipsychotics,":[115],"causes":[116],"apoptosis":[118],"free":[121],"radical":[122],"induced":[123,177],"mechanism,":[124],"involving":[125],"Bcl-XS,":[126],"P53,":[127],"cytochrome":[128],"c":[129],"translocation":[130],"caspase":[132],"3":[133],"activation.":[134],"Haloperidol":[135],"also":[136,169],"lowers":[137],"BDNF":[138],"levels,":[139],"reducing":[140],"neuroprotection":[141],"brain":[144],"enable":[146],"haloperidol's":[147],"toxic":[148],"Atypical":[150,166],"They":[155],"increase":[156],"BDNF,":[159],"improve":[160],"cell":[161],"enhance":[164],"can":[168],"prevent":[170],"or":[171],"reverse":[172],"haloperidol":[176],"toxicity.":[178],"mechanism":[180],"involves":[181],"inverse":[183],"agonism":[184],"5HT":[186],"receptors,":[187],"particularly":[188],"those":[189],"2A":[192],"subset,":[193],"but":[194],"situation":[196],"considerably":[198],"complicated.":[200]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}